ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Accelerated Hepatic Fibrosis after Renal Transplantation: Long-Term Outcomes in HCV+ Patients

J. Scalea, R. Munivenkatappa, V. Whitlow, B. Neuman, S. Fayek, M. Cooper, B. Philosophe

Surgery, Division of Transplantation, University of Maryland, Baltimore, MD

Meeting: 2013 American Transplant Congress

Abstract number: C1303

Related Abstracts
  • There Is No Difference in Patient Survival after Liver Transplantation between Induction with Rabbit ATG and Basiliximab in Recipients with HCV, However, There Appears To Be Less Severe Fibrosis with rATG
  • Long Term Survival After Single Versus Double Lung Transplantation in Patients With Pulmonary Fibrosis in the Modern Era of the Lung Allocation Score

Introduction: It has been demonstrated that hepatitis C+ (HCV+) patients with renal failure benefit from kidney transplantation despite having decreased graft survival compared to HCV- patients. It remains unclear however whether renal transplantation impacts hepatic fibrosis in these patients. Long term outcomes and hepatic fibrosis in HCV+ and HCV- patients following renal transplantation.

Methods: Records from HCV+ and HCV- recipients from 2000 to the present were analyzed. Recipient and donor demographics, 1 and 3 year graft outcome, and graft function (serum creatinine and proteinuria) were evaluated. All HCV+ candidates had a liver biopsy by protocol. Statistical evaluation included ANOVA, Log-rank, Cox multivariate and univariate analyses. Liver biopsies were assessed using Metavir scoring.

Results: Since 2000, 195 HCV+ recipients (R+) received renal transplants from HCV+ donors (D+), in contrast to 1418 HCV- recipients (R-) who received grafts from HCV- donors (D-), and 66 R+ patients that received D- kidneys. For R+/D+ transplants, overall 1 and 5 year renal graft survivals were 87% and 62%, respectively. By multivariate analysis, HCV status, delayed graft function, donor age, and HLA disparity contributed to graft loss (p=0.001) in HCV+ recipients. At 3 years, proteinuria was higher in the HCV+ cohort (p=0.05), although serum creatinine was not different. R+/D+ patients experienced hepatic fibrosis progression from a mean of 0.6 to 1.3, over a mean of 4.8 years (p=0.046). In 7 patients with HCV and ESRD, who had not received a transplant, the mean stage of fibrosis increased from 0.8 to 1.9 over 6.8 years (p=0.062). There was no difference in the fibrosis progression rate in HCV+ patients on dialysis when compared to a demographically similar cohort of HCV+ patients (n=20) without renal failure (0.07/yr and 0.07/yr, respectively, p=0.9). In contrast, the fibrosis progression rate was higher in HCV+ patients post-transplant as compared to HCV+ patients on the waiting list (0.53/yr and 0.07/yr, p=0.002).

Conclusion:

Kidney transplantation in HCV R+/D+ patients is not associated with worse graft survival, when compared with R-/D- patients. However, hepatic fibrosis may increase at a faster rate in this population. Prospective data is needed to confirm these results.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Scalea J, Munivenkatappa R, Whitlow V, Neuman B, Fayek S, Cooper M, Philosophe B. Accelerated Hepatic Fibrosis after Renal Transplantation: Long-Term Outcomes in HCV+ Patients [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/accelerated-hepatic-fibrosis-after-renal-transplantation-long-term-outcomes-in-hcv-patients/. Accessed April 22, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.